Skip to main content

Year: 2021

National Retail Solutions Joins Geopath to Enhance Advertising Audience Measurement Capabilities

Newark, NJ, Dec. 02, 2021 (GLOBE NEWSWIRE) — National Retail Solutions (NRS), a leading point-of-sale (POS) provider for independently owned convenience, liquor, and tobacco stores, today announced that its NRS Digital Media division, which operates NRS’ rapidly expanding digital out-of-home (DOOH) place-based advertising network, has joined Geopath, a non-profit provider of industry-standard out-of-home (OOH) advertising metrics. The integration of Geopath’s audience measurement, consumer insights, and market research equips NRS Digital Media with powerful tools to enhance the reach of its DOOH advertising platform. The platform includes NRS’ network of over 14,000 digital point-of-purchase screens placed with independent retailers across the US providing millions of daily impressions. “Advertisers expect access to robust audience...

Continue reading

Albireo Expands Leadership with Constantine Chinoporos as Chief Business Officer

– New chief business officer to oversee Company’s corporate and business development strategy – BOSTON, Dec. 02, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced the appointment of Constantine Chinoporos as Chief Business Officer and a member of the Albireo Enterprise Leadership Team. Mr. Chinoporos was most recently at Boston Pharmaceuticals where he was the Chief Business Officer responsible for all business development, new product planning operations and in-licensing of 20 programs over his tenure. He brings 30 years of experience in business development, new product planning operations, corporate development, global licensing and divestitures. In this new role, Mr. Chinoporos will be responsible for creating a forward integration...

Continue reading

Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays

78% of People Surveyed Want More Holistic Health Support This SeasonManitoba Harvest.Manitoba Harvest.MINNEAPOLIS and WINNIPEG, Manitoba, Dec. 02, 2021 (GLOBE NEWSWIRE) — Manitoba Harvest, a leading hemp food manufacturer and pioneer in the natural foods industry and a wholly owned subsidiary of Tilray, Inc., introduces a hemp hearts health hack in time for the holidays. As many people jump back into previously paused holiday traditions, it’s important to remember that while this time of year can be joyous, it can also be extremely tiring and stressful. This makes it even more critical to build in simple practices supportive of healthy eating, while still enjoying favorite traditions. Fortunately, Manitoba Harvest, a pioneer and leader in hemp-based foods, offers a simple way to support overall wellbeing by enhancing...

Continue reading

Integer Holdings Corporation Completes Acquisition of Oscor, Inc.

Acquisition expands Integer’s cardiovascular and neurostimulation product portfolio through broadened product offering and addition of low-cost manufacturing capacity PLANO, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer today announced the close of its acquisition of Oscor, Inc., a privately-held company that designs, develops, manufactures and markets a comprehensive portfolio of highly specialized medical devices, venous access systems and diagnostic catheters and implantable devices. From concept to commercialization, Oscor offers its customers a complete line of finished introducer systems, guiding sheaths and proprietary lead wire technologies serving the higher-growth cardiac pacing, electrophysiology, neurostimulation, cardiovascular,...

Continue reading

InterCure Announces European Expansion with International Cannabis Brand Cookies

Leading Global Cannabis Company InterCure Partners with Cookies to Open Retail Locations in Austria and the U.K. in Early 2022 NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 02, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered into a multi-year agreement under which InterCure expects to establish Cookies stores and medical cannabis pharmacies in Austria and the United Kingdom in early 2022, subject to local regulations.  “As we focus on new territories, it’s vital our customers continue to count on the quality Cookies is known for, which is a value we share with our partners at InterCure,” said Parker...

Continue reading

Streamline Health® To Report Third Quarter 2021 Financial Performance and Provide Corporate Update

ATLANTA, GA, Dec. 02, 2021 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and financial performance, today announced that it will release its financial results for the three months ended October 31, 2021 on Wednesday, December 8, 2021 after the close of the financial markets. The Company will conduct a conference call on Thursday, December 9, 2021 at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phone by dialing 877-407-8291. A replay of the conference call will be available from Thursday December 9, 2021 at 12:00 PM ET to Thursday, December 16, 2021 at 12:00 PM ET...

Continue reading

Genius Brands Announces Strategic Investment in Germany’s ‘Your Family Entertainment AG’ Taking Control of One of Europe’s Largest Animation Catalogues and Children’s Broadcasters

Plan to Rebrand Munich-Based Company as Genius Family Entertainment AG, which will Continue to Trade on the Frankfurt Stock Exchange (FRA:RTV) YFE Controls Over 4,000 Animated Episodes and Feature Films, with Distribution through its Streaming and Linear Kid’s Channels Across 100 Countries with More Than 50M Households Reached, including Free-to-Air, Pay TV and Digital Subscription Channels in Germany, Austria & Switzerland Paul Robinson, Former Managing Director of Walt Disney Television International and Senior VP of Disney Channel Worldwide, Will Join the Company as Managing Director of Kartoon Channel! Worldwide, and Oversee the Buildout and Growth of the Global Kartoon Channel! Footprint from the Existing YFE Channel System BEVERLY HILLS, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — Following the recent acquisition of Canada’s...

Continue reading

Harvia starts repurchasing own shares for its incentive plan

Harvia Plc, Stock Exchange Release, December 2nd, 2021 at 3:00 pmThe Board of Directors of Harvia Plc has on the basis of the authorization given by the Annual General Meeting dated 8 April 2021, on December 2nd 2021 decided to start repurchasing the company’s own shares. The shares shall be repurchased to be used as a part of the company’s incentive plan. The maximum number of shares to be acquired is 44,000, corresponding to 0,24% of the total number of shares. The maximum sum to be used for the repurchase is EUR 3,0 million. The shares shall be acquired at market price at the time of purchase through public trading on Nasdaq Helsinki Ltd. The share repurchase shall at the earliest start on 3 December 2021, and end by 7 April 2022. The Annual General Meeting on 8 April 2021 authorized the Board of Directors to decide on the repurchase...

Continue reading

Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure

UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of protein biomarkers in the empagliflozin EMPEROR studies, recently entered the data analysis phase. Empagliflozin, approved in the US under the tradename JARDIANCE, is a product used to lower blood sugar in patients with type 2 diabetes, and also to reduce the risk of cardiovascular death in those with type 2 diabetes who have known cardiovascular disease. JARDIANCE is also under Priority Review at the US FDA as a potential new treatment to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure independent of left ventricular ejection fraction. The sNDA is based on results from the EMPEROR-Preserved...

Continue reading

Clarity Gold Reports High Grade Gold Intercepts, Including 39.29 g/t Au over 0.5 m

Figure 1Location map of drill hole collars DES21-163-167 and DES169-171VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) — Clarity Gold Corp. (“Clarity” or the “Company”) (CSE: CLAR, OTC: CLGCF, FSE: 27G) is pleased to announce the third tranche of analytical results from the approximately 10,800 meter diamond drill program at the Destiny Project in the Abitibi Greenstone Belt. Selected Intercepts DAC ZoneDES21-164: 0.76 g/t Au over 36.65 m and 0.44 g/t Au over 55.9 mDES21-169: 0.42 g/t Au over 43 m and 1.04 g/t Au over 14.45 mDES21-170: 1.22 g/t Au over 30 m including 8.85 g/t Au over 2.55 m and 39.29 g/t Au over 0.5 mDES21-171: 1.34 g/t Au over 14.25 m and 0.78 g/t Au over 37.25 m Selected Intercepts Gap ZoneDES21-165: 0.32 g/t Au over 25.5 m and 0.34 g/t Au over 24 mDES21-167: 1.32 g/t Au over 9.6...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.